Functional magnetic resonance imaging demonstrated changes in brain function and cognitive performance in patients with relapse-remitting multiple sclerosis following a cognitive rehabilitation program.
Functional magnetic resonance imaging (fMRI) demonstrated changes in brain function and cognitive performance in patients with relapse-remitting multiple sclerosis (MS) after they participated in a cognitive rehabilitation program, Italian researchers found. Their study was published today in the journal Radiology.
The small study from the San Raffaele Vita-Salute University in Milan involved 20 patients with MS. Along with many physical symptoms, MS also can cause memory loss and other cognitive effects. Ten patients were controls and the other 10 were assigned to a 12-week computer-assisted cognitive rehabilitation program that worked on attention and information processing, and executive functions.
All 20 patients underwent baseline neuropsychology assessments and fMRI; this was repeated after 12 weeks. Among the patients who participated in the rehabilitation program, the researchers found changes in activity in several brain regions that were not seen in the controls. The researchers did not, however, find any structural changes in the gray matter or normal-appearing with matter.
“The findings demonstrated that computer-assisted cognitive rehabilitation in patients with MS results in an improvement of the trained cognitive functions,” said the study’s lead author, Massimo Filippi, MD. “However, the structural integrity of the brain’s gray matter and white matter showed no modifications in these patients, suggesting an impairment of structural plasticity.”
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
Can AI Automate BPE Assessment of Dense Breasts on MRI?
April 3rd 2024An MRI-based machine learning model demonstrated a comparable background parenchymal enhancement (BPE) hazard ratio to that of manual BPE assessment for breast cancer, according to a study of over 4,500 women with dense breasts.
Are Prostate Biopsies Necessary in Patients with Negative or Equivocal MRIs and Low PSA Density?
April 2nd 2024Up to 48 percent of unnecessary prostate biopsies could be eliminated by limiting biopsy to patients with PI-RADS 4 and higher MRI assessments and a prostate-specific antigen density level below 0.15 ng/mL2, according to a new meta-analysis.